FDA Inspection
Bioreliance CorporationBioreliance Corporation – FDA Inspection, Aug 8, 2019
Record Details
This FDA Inspection record concerns Bioreliance Corporation, with an inspection on August 8, 2019, issued by the Baltimore District Office, covering human drugs.
View Company Profile
ID · 7e151514-be3f-4b8f-ba64-e4ad411f7cc0
Inspection Facts
- Inspection number
- 1099981
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Bioreliance Corporation
11| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2026 | VAI | Baltimore District Office | Bioresearch Monitoring: Human Drugs |
| November 22, 2024 | VAI | Baltimore District Office | Vaccine, Allergenic, and Live Biotherapeutic Products |
| August 4, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 13, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 11, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bioreliance Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.